Emergent Biosolutions (EBS)
(Delayed Data from NYSE)
$8.21 USD
+0.27 (3.40%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $8.22 +0.01 (0.12%) 7:18 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Dividend Yield (TTM)
Emergent Biosolutions Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
EBS 8.21 +0.27(3.40%)
Will EBS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for EBS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EBS
5 Broker-Loved Stocks Amid EU Tariff Pause & Consumer Confidence Boost
Zacks.com featured highlights include BrightSpring Health Services, Beyond, Air Canada, HF Sinclair and Emergent BioSolutions
EBS: What are Zacks experts saying now?
Zacks Private Portfolio Services
5 Broker-Loved Stocks to Watch Amid Signs of Easing Trade Woes
Emergent Biosolutions (EBS) Q1 Earnings Top Estimates
Axsome (AXSM) Moves 4.2% Higher: Will This Strength Last?
Other News for EBS
Emergent BioSolutions (EBS) Lands $29M International Supply Agreement
Emergent BioSolutions (EBS) Lands $29 Million Government Contract
Emergent Biosolutions secures $29M in MCM product orders from international government partner
Emergent BioSolutions secures $29M in MCM product orders
Emergent BioSolutions secures $29M in MCM product orders